A University of Queensland start-up company developing rapid serum blood collection tube technology will be manufactured and used in Japan after it partnered with the country’s leading medical device company, Terumo Corporation.
Q-Sera Pty Ltd, founded by UQ’s commercialisation company UniQuest in 2012 based on UQ intellectual property, has proprietary technology that clots blood samples more quickly and effectively, particularly for patients on blood thinning medication, to produce high-quality serum for analysis.
Blood serum tests are commonly used to assist in the accurate diagnosis of medical problems from heart attacks to diabetes in hospital and community settings.
The blood clotting technology was developed from the work of Professor Martin Lavin from the UQ Centre for Clinical Research, the late Dr Paul Masci from UQ’s Faculty of Medicine, Emeritus Professor John de Jersey from UQ’s School of Chemistry and Molecular Biosciences and Dr Goce Dimeski, chief scientist in chemical pathology at Princess Alexandra Hospital.
The deal with Terumo Corporation will see Q-Sera’s innovative RAPClotTM rapid serum tube technology manufactured and used in Japan.
The serum tubes produce high-quality serum in less than five minutes, reducing the turnaround time from sample collection to serum analysis compared with current technologies.
